Free nerve ending (FNE)

A **free nerve ending** is the terminal portion of a sensory neuron that lacks a specialized capsule or structure and is found predominantly in the skin, mucosa, and various internal tissues[1][6][7]. Free nerve endings are the most common sensory receptor type in vertebrates and function as the principal detectors for noxious stimuli (nociceptors), as well as mediators of thermoreception and some mechanoreception[1][3][4][5][6]. Structurally, they are unmyelinated or thinly myelinated terminal branches (mostly from Aδ and C fibers), which ramify throughout the tissue, especially the dermal and epidermal layers of the skin[1][4][5]. These endings play a critical role in pain perception by transducing mechanical, chemical, and thermal stimuli into nerve impulses that are conducted to the spinal cord and brain[4][5]. They are not a single molecular entity but a general morphological class of peripheral afferent nerve terminal; therefore, they are not a distinct druggable “target” in the molecular pharmacology sense, but they are important for understanding sensory transduction and pain pathways[4][5]. **Note:** - "Free nerve ending" is a morphological structure, **not a single protein, receptor, or typical molecular drug target**. - The classification as a therapeutic target is incorrect in the conventional drug development sense, and querying its drug interactions or unique molecular biomarkers is not applicable. - Return entries such as mechanism_of_action, interacting_drugs, and biomarkers as null if structured data is needed, as there is no direct “target” of this name. - If a specific receptor (e.g., TRPV1, Nav1.7) expressed on free nerve endings is intended, those should be searched as distinct targets.

Other names

bare nerve endingunencapsulated nerve ending